Total Payments
$66,639
2024 Payments
$266.01
Companies
24
Transactions
253
Medicare Patients
6,553
Medicare Billing
$329,775
Payment Breakdown by Category
Other$50,400 (75.6%)
Food & Beverage$10,117 (15.2%)
Travel$4,815 (7.2%)
Consulting$1,000 (1.5%)
Education$306.80 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,400 | 17 | 75.6% |
| Food and Beverage | $10,117 | 205 | 15.2% |
| Travel and Lodging | $4,815 | 19 | 7.2% |
| Consulting Fee | $1,000 | 4 | 1.5% |
| Education | $306.80 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $42,520 | 68 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $12,940 | 35 | $0 (2023) |
| Abbott Laboratories | $2,225 | 15 | $0 (2023) |
| Amgen Inc. | $2,199 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,376 | 32 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $1,245 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,030 | 14 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $778.10 | 11 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $423.90 | 7 | $0 (2023) |
| PFIZER INC. | $320.33 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $266.01 | 15 | ABIOMED ($192.50) |
| 2023 | $1,513 | 33 | E.R. Squibb & Sons, L.L.C. ($375.65) |
| 2022 | $671.76 | 14 | E.R. Squibb & Sons, L.L.C. ($193.99) |
| 2021 | $1,076 | 19 | AstraZeneca Pharmaceuticals LP ($429.39) |
| 2020 | $680.69 | 11 | Janssen Pharmaceuticals, Inc ($180.58) |
| 2019 | $14,943 | 44 | Novartis Pharmaceuticals Corporation ($10,331) |
| 2018 | $14,906 | 48 | Novartis Pharmaceuticals Corporation ($9,913) |
| 2017 | $32,582 | 69 | Novartis Pharmaceuticals Corporation ($21,757) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $34.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $37.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $7.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $4.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $3.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $73.51 | General |
| 12/21/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.27 | General |
| Category: Cardiovascular | ||||||
| 12/19/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $95.40 | General |
| Category: Cardiovascular | ||||||
| 12/05/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $102.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $58.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $102.64 | General |
| Category: DIABETES | ||||||
| 10/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $132.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Cardiovascular | ||||||
| 09/19/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $0.78 | General |
| Category: Cardiovascular | ||||||
| 08/29/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $108.12 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,174 | 1,347 | $199,936 | $64,261 |
| 2022 | 22 | 1,497 | 1,735 | $250,663 | $77,348 |
| 2021 | 24 | 1,796 | 2,056 | $297,149 | $92,246 |
| 2020 | 26 | 2,086 | 2,389 | $337,749 | $95,920 |
Total Patients
6,553
Total Services
7,527
Medicare Billing
$329,775
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 147 | 228 | $28,944 | $15,500 | 53.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 273 | 283 | $62,826 | $13,844 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 67 | 80 | $15,168 | $8,151 | 53.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 55 | $20,515 | $7,506 | 36.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 76 | 76 | $18,088 | $4,145 | 22.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 35 | $6,405 | $3,185 | 49.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 48 | $6,096 | $2,926 | 48.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,080 | $2,050 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 28 | $2,156 | $1,365 | 63.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 157 | 213 | $16,672 | $1,203 | 7.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 15 | 15 | $3,570 | $857.83 | 24.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 79 | 79 | $3,002 | $800.99 | 26.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 14 | 14 | $3,108 | $686.62 | 22.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 29 | 30 | $2,430 | $582.60 | 24.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 38 | 38 | $2,204 | $543.18 | 24.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 17 | 17 | $1,428 | $483.04 | 33.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 36 | 36 | $1,008 | $190.40 | 18.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 15 | 15 | $570.00 | $157.21 | 27.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 37 | 37 | $666.00 | $83.65 | 12.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 133 | 165 | $30,316 | $16,756 | 55.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 143 | 207 | $27,304 | $14,911 | 54.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 290 | 298 | $66,156 | $14,002 | 21.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 62 | $23,126 | $9,070 | 39.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 80 | 80 | $19,040 | $4,258 | 22.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 61 | $7,747 | $3,167 | 40.9% |
About Anthony King
Anthony King is a Cardiovascular Disease healthcare provider based in Kalamazoo, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194700104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony King has received a total of $66,639 in payments from pharmaceutical and medical device companies, with $266.01 received in 2024. These payments were reported across 253 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,400).
As a Medicare-enrolled provider, King has provided services to 6,553 Medicare beneficiaries, totaling 7,527 services with total Medicare billing of $329,775. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Kalamazoo, MI
- Active Since 12/13/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1194700104
Products in Payments
- ENTRESTO (Drug) $42,423
- ELIQUIS (Drug) $12,562
- CardioMEMS HF System (Device) $1,834
- MK-1242 (Drug) $1,245
- XARELTO (Drug) $1,221
- JARDIANCE (Drug) $894.19
- Repatha (Biological) $699.83
- FARXIGA (Drug) $527.98
- LifeVest (Device) $423.90
- CAMZYOS (Drug) $397.88
- BRILINTA (Drug) $250.12
- INVOKANA (Drug) $218.97
- PRALUENT (Drug) $193.42
- Impella (Device) $192.50
- Barostim Neo System (Device) $155.45
- HeartMate 3 Left Ventricular Dev (Device) $142.44
- CARDIOMEMS (Device) $138.12
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $126.18
- Veltassa (Drug) $118.88
- HeartMate 3 Left Ventricular Assist Device (Device) $110.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Kalamazoo
Dr. Vishal Gupta, M.d, M.D
Cardiovascular Disease — Payments: $423,224
Cardiovascular Disease $423,224
Dr. Robert Williams, D.o, D.O
Cardiovascular Disease — Payments: $55,563
Cardiovascular Disease $55,563
Dr. Christopher Rogers, D.o, D.O
Cardiovascular Disease — Payments: $34,998
Cardiovascular Disease $34,998
Frank Saltiel, M.d, M.D
Cardiovascular Disease — Payments: $29,179
Cardiovascular Disease $29,179
Michael Pack, Do, DO
Cardiovascular Disease — Payments: $28,931
Cardiovascular Disease $28,931
Brett Eliuk, D.o, D.O
Cardiovascular Disease — Payments: $22,954
Cardiovascular Disease $22,954